| Financial Year |
March 31 2023 |
| Monetary Funds |
620,391,668.25 |
| Held-for-trading Financial Assets |
49,025,004.12 |
| Notes Receivable |
10,334,088.81 |
| Accounts Receivable |
432,832,697.33 |
| Advances to Suppliers |
70,177,276.90 |
| Other Receivables |
92,412,512.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,336,314.54 |
| Inventories |
126,809,405.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,243,459.10 |
| Other Current Assets |
170,769,364.74 |
| Total Current Assets |
1,575,995,477.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,869,773.85 |
| Long-term Equity Investment |
1,154,319,777.94 |
| Investment Properties |
9,001,609.80 |
| Fixed Assetes |
6,292,485,819.70 |
| Under-construction Projects |
499,390,253.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
326,469,134.90 |
| R&D expenses |
-- |
| Goodwill |
80,331,892.62 |
| Long-Term Deferred and Prepaid Expenses |
15,258,509.88 |
| Deferred Income Tax Assets |
63,019,648.37 |
| Other Non-Current Assets |
14,906,570.05 |
| Sub-Total of Non-Current Assets |
8,713,257,557.42 |
| Total Assets |
10,289,253,034.91 |
| Short-Term Loans |
316,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
439,017,918.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
68,460,665.44 |
| Taxes Payable |
51,554,942.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
334,007,864.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
395,654,614.56 |
| Other Current Liabilities |
218,004,737.61 |
| Sub-Total of Current Liabilities |
2,266,699,706.62 |
| Long-term Loans |
1,664,283,489.34 |
| Bonds Payable |
334,071,582.79 |
| Long-Term Accounts Payable |
1,080,433,601.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,500,000.00 |
| Deferred Income Tax Liabilities |
51,300,873.51 |
| Other Non-Current Liabilities |
150,000,000.00 |
| Sub-Total of Non-Current Liabilities |
3,577,462,973.31 |
| Total Liabilities |
5,844,162,679.93 |
| Paid-In Capital(Or Share Stock) |
1,232,259,790.00 |
| Capital Surplus |
1,511,953,001.20 |
| Surplus Reserve |
207,169,666.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,272,248,953.18 |
| Minority Stockholder's Interest |
213,297,440.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,231,792,914.97 |
| Owner's Equity（Stockholder's Equity） |
4,445,090,354.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,289,253,034.91 |
